One of the more important decisions someone makes as they near retirement is where to retire. Of course, factors like weather and proximity to family are important. But so are the financial implications and potential treatment you'll receive in various states. If you want your retirement nest egg to last as long as possible, saving money wherever you can (especially on taxes) is never a bad idea. ...
One of the more important decisions someone makes as they near retirement is where to retire. Of course, factors like weather and proximity to family are important. But so are the financial implications and potential treatment you'll receive in various states. If you want your retirement nest egg to last as long as possible, saving money wherever you can (especially on taxes) is never a bad idea. Tax benefits vary by state , but if you're looking for the most tax-friendly options, consider the following 13 that don't tax retirement income. Image source: Getty Images. Continue reading
uniQure ( QURE ) shares jumped ~22% on Thursday after the Dutch biotech announced positive regulatory developments related to its gene therapy candidate AMT-130 at a time when its U.S. approval remains uncertain. The company disclosed plans to submit a marketing authorization
uniQure ( QURE ) shares jumped ~22% on Thursday after the Dutch biotech announced positive regulatory developments related to its gene therapy candidate AMT-130 at a time when its U.S. approval remains uncertain. The company disclosed plans to submit a marketing authorization
Wall Street is responding to Alphabet‘s (NASDAQ:GOOGL) blowout Q1 2026 report with a synchronized wave of price target hikes. At least six firms raised targets on April 30, with Susquehanna lifting to $460 from $400, Canaccord to $450 from $415, and TD Cowen to $450 from $375, calling the cloud number a “monster” AI inflection ... Wall Street Lifts Alphabet Price Targets After Cloud’s 63% Growth: ...
Wall Street is responding to Alphabet‘s (NASDAQ:GOOGL) blowout Q1 2026 report with a synchronized wave of price target hikes. At least six firms raised targets on April 30, with Susquehanna lifting to $460 from $400, Canaccord to $450 from $415, and TD Cowen to $450 from $375, calling the cloud number a “monster” AI inflection ... Wall Street Lifts Alphabet Price Targets After Cloud’s 63% Growth: Is the AI Stack Story Just Getting Started?
In this article BAYERCROP-IN Follow your favorite stocks CREATE FREE ACCOUNT watch now VIDEO 6:37 06:37 Weed killer glyphosate pits Trump against his MAHA base Politics The House of Representatives on Thursday stripped a set of controversial provisions aimed at protecting pesticide manufacturers from the farm bill , following a Make America Healthy Again uprising that could have sunk the broader p...
In this article BAYERCROP-IN Follow your favorite stocks CREATE FREE ACCOUNT watch now VIDEO 6:37 06:37 Weed killer glyphosate pits Trump against his MAHA base Politics The House of Representatives on Thursday stripped a set of controversial provisions aimed at protecting pesticide manufacturers from the farm bill , following a Make America Healthy Again uprising that could have sunk the broader package. The amendment led by Rep. Anna Paulina Luna, R-Fla, to strip the language was passed by a vote of 280-142, after a bipartisan groundswell of opposition from lawmakers and MAHA advocates who said the provisions amounted to a "liability shield" to protect Bayer from allegations that its Roundup herbicide and its chemical glyphosate cause cancer. The broader farm bill cleared the House Thursday morning by a vote of 224-200. Rep. Chellie Pingree, D-Maine, who was helping lead the push to strip the pesticide language for Democrats, said the language represented a "handout to big agriculture, to big chemical." "It preempts states' rights to regulate pesticide usage or labeling [and] provides a liability shield for pesticide manufacturers," Pingree said on the House floor. "Put simply, this language puts chemical company profits over the health of Americans." A sign protesting Chairman Glenn Thompson's Farm Bill in Washington DC, on April 30, 2026. Angela Greiling Keane | CNBC A litany of lawsuits over years have claimed glyphosate causes cancer and Bayer and Monsanto, which manufactured Roundup before the German pharmaceutical giant acquired it, have frequently been found liable for failing to warn of cancer risk. The Environmental Protection Agency does not classify glyphosate as a carcinogen and does not require labels to disclose cancer risk, but the World Health Organization 's International Agency for Research on Cancer in 2015 said the chemical is "probably carcinogenic to humans." The language in the bill would have prohibited any states and courts from penalizing ...
Hospitals across the country are bracing for financial pain ahead of sweeping Medicaid cuts from the Trump administration. But that hasn’t stopped them from borrowing at the fastest pace in more than a decade. So far this year, US hospitals have sold more than $17 billion of municipal bonds, roughly double the pace of 2025, and more in the first four months than any year since at least 2015, accor...
Hospitals across the country are bracing for financial pain ahead of sweeping Medicaid cuts from the Trump administration. But that hasn’t stopped them from borrowing at the fastest pace in more than a decade. So far this year, US hospitals have sold more than $17 billion of municipal bonds, roughly double the pace of 2025, and more in the first four months than any year since at least 2015, according to data compiled by Bloomberg. The surge also surpasses the broader muni market, where issuance is up about 9% this year. Many facilities are taking advantage of what looks like a prime window to sell debt. Balance sheets have recovered since the pandemic, but most Medicaid changes have yet to take effect . Ahead of a potential credit rating hit, many are choosing to borrow to upgrade aging buildings and expand their footprints. “Clients generally have improved financial performance relative to the last several years – focusing on strengthening both the income statements and balance sheets. In many cases, they are as strong as they’ve been for a while,” said Robert Turner, managing director and practice lead at healthcare consultant Kaufman Hall. “When you look around the corner at Medicaid cuts and federal funding pressures, they’re wondering if this is as good as it’s going to be for some time.” Not-for-profit hospitals have largely seen their finances rebound from post-pandemic lows, according to a December report by Fitch Ratings , and the ratio of downgrades to upgrades has improved. The ratings company forecasts hospitals will accelerate efforts to boost revenue and cut expenses ahead of the anticipated cuts from the federal government, which don’t go into full effect until after 2026 and are expected to increase the number of uninsured people by 10 million in 2034. Read More: How Medicaid Cuts Will Hit Low-Income Americans: QuickTake Still, analysts at Nuveen LLC see the issuance surge in the muni market continuing “as waning fiscal stimulus and federal funding ...
Daniel Alegre, CEO, TelevisaUnivision discusses global sports media economics and Spanish-language audience growth with Bloomberg’s Dani Burger at Bloomberg House Miami 2026. (Source: Bloomberg)
Daniel Alegre, CEO, TelevisaUnivision discusses global sports media economics and Spanish-language audience growth with Bloomberg’s Dani Burger at Bloomberg House Miami 2026. (Source: Bloomberg)
IherPhoto/iStock via Getty Images By Paolo Pizzoli , Senior Economist, Italy, Greece After a subdued reading in March, possibly helped by the fading impact of February’s Winter Olympics, Italian inflation accelerated in April, increasingly reflecting the impact of the war in the Middle
IherPhoto/iStock via Getty Images By Paolo Pizzoli , Senior Economist, Italy, Greece After a subdued reading in March, possibly helped by the fading impact of February’s Winter Olympics, Italian inflation accelerated in April, increasingly reflecting the impact of the war in the Middle
Justin Sullivan/Getty Images News Yesterday, Alphabet Inc. ( GOOG ) ( GOOGL ), better known as Google, released its first-quarter earnings . The reported numbers—revenue, reported earnings per share (EPS), and adjusted EPS—all exceeded expectations by wide margins. Particularly impressive
Justin Sullivan/Getty Images News Yesterday, Alphabet Inc. ( GOOG ) ( GOOGL ), better known as Google, released its first-quarter earnings . The reported numbers—revenue, reported earnings per share (EPS), and adjusted EPS—all exceeded expectations by wide margins. Particularly impressive
Justin Sullivan/Getty Images News Yesterday, Alphabet Inc. ( GOOG ) ( GOOGL ), better known as Google, released its first-quarter earnings . The reported numbers—revenue, reported earnings per share (EPS), and adjusted EPS—all exceeded expectations by wide margins. Particularly impressive
Justin Sullivan/Getty Images News Yesterday, Alphabet Inc. ( GOOG ) ( GOOGL ), better known as Google, released its first-quarter earnings . The reported numbers—revenue, reported earnings per share (EPS), and adjusted EPS—all exceeded expectations by wide margins. Particularly impressive
CNBC's Jim Cramer is disappointed with Microsoft 's latest quarter but did see some positives. Microsoft's report overall Wednesday evening "was not joyous," Cramer said on " Squawk on the Street " as shares were dropping 5%. They are down more than 16% year to date. In fact, Cramer ranked Microsoft performance near bottom among Alphabet , Meta , and Amazon — which all reported quarterly results a...
CNBC's Jim Cramer is disappointed with Microsoft 's latest quarter but did see some positives. Microsoft's report overall Wednesday evening "was not joyous," Cramer said on " Squawk on the Street " as shares were dropping 5%. They are down more than 16% year to date. In fact, Cramer ranked Microsoft performance near bottom among Alphabet , Meta , and Amazon — which all reported quarterly results after Wednesday's close. He put Meta dead last. "I do not think that you need to buy Microsoft here," Cramer later said during the CNBC's Investing Club Morning Meeting. The tech giant is Club holding. MSFT YTD mountain Microsoft YTD The software and cloud giant did deliver a better-than-expected quarter, issuing strong guidance for its critical Azure cloud business. Microsoft forecasted Azure cloud growth between 39% and 40%, above Street consensus of 37%. Cloud revenue rose over $54 billion for the quarter, up 29% year over year. "A lot of people got excited about that [Azure's guidance], but it turned out that there's a lot of aspects of Microsoft that just feel like software," Cramer said. That's why the stock was getting dinged. Among the chief concerns is Microsoft's seat-based business model of its Office suite, which Wall Street largely believes is being threatened AI code-writing. The worries aren't enough to temper Wall Street's majority bullish sentiment on Microsoft's stock. "I couldn't believe it," Cramer said, pointing to the slew of positive post-earnings reactions and buy ratings from Street analysts like Bank of America, Morgan Stanley, and Goldman Sachs. Cramer reiterated his stance. "I have no interest in buying Microsoft." Jim Cramer ranks hyperscalers' earnings Alphabet is winner, sees more upside ahead Amazon going up another 15% and not stopping there Far from impressed with Microsoft earnings. Here's why Don't let Meta's post-earnings plunge scare you out of the stock
The Board of Directors of Hershey today announced quarterly dividends of $1.452 on the Common Stock and $1.320 on the Class B Common Stock. The dividends were declared April 29, 2026, and are payable June 15, 2026, to stockholders of record as of May 15, 2026. It is the 385th co
The Board of Directors of Hershey today announced quarterly dividends of $1.452 on the Common Stock and $1.320 on the Class B Common Stock. The dividends were declared April 29, 2026, and are payable June 15, 2026, to stockholders of record as of May 15, 2026. It is the 385th co
In trading on Thursday, hospital & medical practitioners shares were relative laggards, down on the day by about 1.4%. Helping drag down the group were shares of Acadia Healthcare Company, down about 18.4% and shares of Agilon Health off about 5% on the day. Also lagging t
In trading on Thursday, hospital & medical practitioners shares were relative laggards, down on the day by about 1.4%. Helping drag down the group were shares of Acadia Healthcare Company, down about 18.4% and shares of Agilon Health off about 5% on the day. Also lagging t
In trading on Thursday, computer peripherals shares were relative leaders, up on the day by about 12.5%. Leading the group were shares of Xerox Holdings, up about 45.2% and shares of Silicom up about 33.8% on the day. Also showing relative strength are construction shares, up
In trading on Thursday, computer peripherals shares were relative leaders, up on the day by about 12.5%. Leading the group were shares of Xerox Holdings, up about 45.2% and shares of Silicom up about 33.8% on the day. Also showing relative strength are construction shares, up
Canada Packers Inc. press release ( CPKR:CA ): Q1 Non-GAAP EPS of $0.54. Revenue of $428.3M (-5.2% Y/Y). More on Canada Packers Inc. Historical earnings data for Canada Packers Inc. Dividend scorecard for Canada Packers Inc. Financial information for Canada Packers Inc.
Canada Packers Inc. press release ( CPKR:CA ): Q1 Non-GAAP EPS of $0.54. Revenue of $428.3M (-5.2% Y/Y). More on Canada Packers Inc. Historical earnings data for Canada Packers Inc. Dividend scorecard for Canada Packers Inc. Financial information for Canada Packers Inc.
On April 30, Oppenheimer initiated coverage of Palantir (NASDAQ:PLTR) stock with an Outperform rating and a $200 price target. The bullish call rests on Palantir’s Ontology-anchored architecture, which the firm believes creates considerable switching costs once embedded, alongside defense technology tailwinds and rapid commercial expansion. For long-term investors, the initiation lands as a fresh ...
On April 30, Oppenheimer initiated coverage of Palantir (NASDAQ:PLTR) stock with an Outperform rating and a $200 price target. The bullish call rests on Palantir’s Ontology-anchored architecture, which the firm believes creates considerable switching costs once embedded, alongside defense technology tailwinds and rapid commercial expansion. For long-term investors, the initiation lands as a fresh institutional ... Oppenheimer Initiates Palantir With Outperform and $200 Price Target: Is the AI Ap